English
Cancer stem cells (CSCs) contribute to therapeutic resistance, metastatic progression, and tumor recurrence, yet
the metabolic pathways that sustain their survival remain incompletely understood. Here, we identify 3-mercaptopyruvate
sulfurtransferase (3-MST), a hydrogen sulfide–producing enzyme encoded by MPST, as a metabolic
dependency of colorectal CSCs. 3-MST expression was increased in human colorectal tumors and cancer cell lines
and strongly correlated with proliferative capacity. HCT116-derived CSCs exhibited elevated 3-MST expression,
increased hydrogen sulfide and reactive sulfur species production, altered membrane rigidity, and a metabolically
restrained phenotype characterized by low basal oxidative phosphorylation and glycolysis. Genetic
depletion of 3-MST preferentially impaired CSC proliferation, spheroid formation, stem-like properties, and
migration, with less pronounced effects in differentiated parental cells. Pharmacological inhibition of 3-MST
reproduced these effects across CSCs derived from several colorectal cancer cell lines and induced nearcomplete
suppression of mitochondrial respiration and glycolytic activity. 3-MST inhibition also increased
membrane fluidity, promoted cell death, and reduced CSC-derived tumor growth in mice. Integrated transcriptomic,
proteomic, metabolomic, and lipidomic analyses demonstrated coordinated disruption of mitochondrial
carbon metabolism, respiratory-chain maintenance, lipid desaturation, and membrane phospholipid
homeostasis. These changes were accompanied by accumulation of free fatty acids and diacylglycerols and
activation of antioxidants, integrated stress-response, endoplasmic-reticulum-stress, apoptotic, and p53-
associated pathways. Ferroptosis-related molecular signatures were also enriched. These findings identify 3-
MST as a critical regulator of colorectal CSC bioenergetics and membrane homeostasis and reveal a therapeutically
exploitable metabolic vulnerability in treatment-resistant colorectal cancer.